Related references
Note: Only part of the references are listed.Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010
Zaven S. Khachaturian et al.
ALZHEIMERS & DEMENTIA (2011)
Alzheimer's Association Report 2011 Alzheimer's disease facts and figures
ALZHEIMERS & DEMENTIA (2011)
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2011)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Amyloid-like Aggregates Sequester Numerous Metastable Proteins with Essential Cellular Functions
Heidi Olzscha et al.
CELL (2011)
The influence of ApoE4 on clinical progression of dementia: a meta-analysis
Charlotte L. Allan et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
Large Quantities of Aβ Peptide Are Constitutively Released during Amyloid Precursor Protein Metabolism in Vivo and in Vitro
Abhay Moghekar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
PSENEN and NCSTN Mutations in Familial Hidradenitis Suppurativa (Acne Inversa)
Andrew E. Pink et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Amyloid-β/Fyn-Induced Synaptic, Network, and Cognitive Impairments Depend on Tau Levels in Multiple Mouse Models of Alzheimer's Disease
Erik D. Roberson et al.
JOURNAL OF NEUROSCIENCE (2011)
Long-Term In Vivo Imaging of β-Amyloid Plaque Appearance and Growth in a Mouse Model of Cerebral β-Amyloidosis
Jasmin K. Hefendehl et al.
JOURNAL OF NEUROSCIENCE (2011)
Onset and Rate of Cognitive Change Before Dementia Diagnosis: Findings From Two Swedish Population-Based Longitudinal Studies
Valgeir Thorvaldsson et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2011)
Alzheimer's disease: clinical trials and drug development (vol 9, pg 702, 2010)
F. Mangialasche et al.
LANCET NEUROLOGY (2011)
Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study
Natalia Acosta-Baena et al.
LANCET NEUROLOGY (2011)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth et al.
NATURE GENETICS (2011)
Potent amyloidogenicity and pathogenicity of Aβ43
Takashi Saito et al.
NATURE NEUROSCIENCE (2011)
Anti-Aβ Therapeutics in Alzheimer's Disease: The Need for a Paradigm Shift
Todd E. Golde et al.
NEURON (2011)
Alzheimer's Disease: The Challenge of the Second Century
David M. Holtzman et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Immunotherapy with bapineuzumab lowers CSF tau protein levels in patients with Alzheimer's disease
Kaj Blennow et al.
Alzheimers & Dementia (2010)
APOE Predicts Amyloid-Beta but Not Tau Alzheimer Pathology in Cognitively Normal Aging
John C. Morris et al.
ANNALS OF NEUROLOGY (2010)
Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
Geert De Meyer et al.
ARCHIVES OF NEUROLOGY (2010)
Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
Irina Kuperstein et al.
EMBO JOURNAL (2010)
Targeting Aβ and tau in Alzheimer's disease, an early interim report
Todd E. Golde et al.
EXPERIMENTAL NEUROLOGY (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease
Erik Portelius et al.
MOLECULAR NEURODEGENERATION (2010)
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Christopher C. Rowe et al.
NEUROBIOLOGY OF AGING (2010)
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
Bart De Strooper
PHYSIOLOGICAL REVIEWS (2010)
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease
Lesley Jones et al.
PLOS ONE (2010)
γ-Secretase Gene Mutations in Familial Acne Inversa
Baoxi Wang et al.
SCIENCE (2010)
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche et al.
LANCET NEUROLOGY (2010)
Current Alzheimer's disease clinical trials: Methods and placebo outcomes
Lon S. Schneider et al.
ALZHEIMERS & DEMENTIA (2009)
A γ-Secretase Inhibitor Decreases Amyloid-β Production in the Central Nervous System
Randall J. Bateman et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease
Anne M. Fagan et al.
EMBO MOLECULAR MEDICINE (2009)
Equal Numbers of Neuronal and Nonneuronal Cells Make the Human Brain an Isometrically Scaled-Up Primate Brain
Frederico A. C. Azevedo et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2009)
Aβ43 is more frequent than Aβ40 in amyloid plaque cores from Alzheimer disease brains
Hedvig Welander et al.
JOURNAL OF NEUROCHEMISTRY (2009)
γ-Secretase: Successive Tripeptide and Tetrapeptide Release from the Transmembrane Domain of β-Carboxyl Terminal Fragment
Mako Takami et al.
JOURNAL OF NEUROSCIENCE (2009)
Characterizing the Appearance and Growth of Amyloid Plaques in APP/PS1 Mice
Ping Yan et al.
JOURNAL OF NEUROSCIENCE (2009)
Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575
Monica Garcia-Alloza et al.
MOLECULAR NEURODEGENERATION (2009)
Transmission and spreading of tauopathy in transgenic mouse brain
Florence Clavaguera et al.
NATURE CELL BIOLOGY (2009)
Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease
Summer L. Bernstein et al.
NATURE CHEMISTRY (2009)
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2009)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold et al.
NATURE GENETICS (2009)
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
Joseph L. Price et al.
NEUROBIOLOGY OF AGING (2009)
Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease
E. Hellstrom-Lindahl et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
The Role of Apolipoprotein E in Alzheimer's Disease
Jungsu Kim et al.
NEURON (2009)
Age, Neuropathology, and Dementia
George M. Savva et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Dementia of the Alzheimer Type
Jessica J. Jalbert et al.
EPIDEMIOLOGIC REVIEWS (2008)
Dynamics of Aβ Turnover and Deposition in Different β-Amyloid Precursor Protein Transgenic Mouse Models Following γ-Secretase Inhibition
Dorothee Abramowski et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Survival in Alzheimer disease A multiethnic, population-based study of incident cases
E. P. Helzner et al.
NEUROLOGY (2008)
Presenilins:: Members of the γ-secretase quartets, but part-time soloists too
Tomoko Wakabayashi et al.
PHYSIOLOGY (2008)
Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice
Lisa McConlogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
When loss is gain:: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40 -: Talking Point on the role of presenilin mutations in Alzheimer disease
Michael S. Wolfe
EMBO REPORTS (2007)
Loss-of-function presenilin mutations in Alzheimer disease - Talking Point on the role of presenilin mutations in Alzheimer disease
Bart De Strooper
EMBO REPORTS (2007)
Aβ40 inhibits amyloid deposition in vivo
Jungsu Kim et al.
JOURNAL OF NEUROSCIENCE (2007)
The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism
Jie Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Solution state characterization of amyloid β-derived diffusible ligands
Robert W. Hepler et al.
BIOCHEMISTRY (2006)
Concentration-dependent modulation of amyloid-β in vivo and in vitro using the γ-secretase inhibitor, LY-450139
Thomas A. Lanz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host
Melanie Meyer-Luehmann et al.
SCIENCE (2006)
Human amyloid-β synthesis and clearance rates as measured in cerebrospinal fluid in vivo
Randall J. Bateman et al.
NATURE MEDICINE (2006)
Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40
Samir Kumar-Singh et al.
HUMAN MUTATION (2006)
Common mechanisms of amyloid oligomer pathogenesis in degenerative disease
CG Glabe
NEUROBIOLOGY OF AGING (2006)
DAPT-induced intracellular accumulations of longer amyloid β-proteins:: Further implications for the mechanism of intramembrane cleavage by γ-secretase
S Yagishita et al.
BIOCHEMISTRY (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Presenilin clinical mutations can affect γ-secretase activity by different mechanisms
M Bentahir et al.
JOURNAL OF NEUROCHEMISTRY (2006)
The cerebral beta-amyloid angiopathies: Hereditary and sporadic
SX Zhang-Nunes et al.
BRAIN PATHOLOGY (2006)
beta-amyloid degradation and Alzheimer's disease
Deng-Shun Wang et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life
BJ Snider et al.
ARCHIVES OF NEUROLOGY (2005)
Persistent amyloidosis following suppression of Aβ production in a transgenic model of Alzheimer disease
JL Jankowsky et al.
PLOS MEDICINE (2005)
Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: 'permissive templating' as a general mechanism underlying neurodegeneration
J Hardy
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
Alzheimer disease and mortality - A 15-year epidemiological study
M Ganguli et al.
ARCHIVES OF NEUROLOGY (2005)
The clinical syndrome of Alzheimer's disease: aspects particularly relevant to clinical trials
RC Mohs
GENES BRAIN AND BEHAVIOR (2005)
Differential contribution of the three Aph1 genes to γ-secretase activity in vivoi
L Serneels et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Survival after initial diagnosis of Alzheimer disease
EB Larson et al.
ANNALS OF INTERNAL MEDICINE (2004)
Reduced β-amyloid burden, increased C-99 concentrations and evaluation of neuropathology in the brains of PDAPP mice given LY450139 dihydrate daily by gavage for 5 months
DK Ness et al.
NEUROBIOLOGY OF AGING (2004)
The natural history of Alzheimer disease - A longitudinal presymptomatic and symptomatic study of a familial cohort
AK Godbolt et al.
ARCHIVES OF NEUROLOGY (2004)
Apolipoprotein Eε4 modifies Alzheimer's disease onset in an E280A PS1 kindred
P Pastor et al.
ANNALS OF NEUROLOGY (2003)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease
A Delacourte et al.
NEUROLOGY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
APOE genotype and survival in men and women with Alzheimer's disease
G Dal Forno et al.
NEUROLOGY (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Brain to plasma amyloid-β efflux:: a measure of brain amyloid burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
SCIENCE (2002)
Genotype and phenotype in Alzheimer's disease
C Holmes
BRITISH JOURNAL OF PSYCHIATRY (2002)
The clinical phenotype of familial and sporadic late onset Alzheimer's disease
C Holmes et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2002)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Clearance of Alzheimer's amyloid-β1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier
M Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene
DA Nickerson et al.
GENOME RESEARCH (2000)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism
WP Esler et al.
BIOCHEMISTRY (2000)
Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
J Näslund et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
DM Holtzman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein
XL Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma:: Suppression leads to biochemical and pathological deposition
N Iwata et al.
NATURE MEDICINE (2000)
Share Paper
